HealthLife Style

USFDA grants Breakthrough Designation to Datar Cancer Genetics for blood test detecting prostate cancer

The approved blood test can detect early-stage prostate cancers with more than 99 percent accuracy without any false positives. It has been validated in large clinical studies involving healthy males and prostate cancer patients.

Related Articles

Back to top button